Elucid
PrivateLast Round
Series C
Nov 9, 2023
Total Funding Raised
$115M
Momentum Score
25 /100
Company Overview
Elucid is a healthcare technology company that develops an imaging system utilizing artificial intelligence to enhance patient outcomes and reduce costs in vascular diagnostic imaging.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elucid Comps
Public and private peers based on sector, stage, and business model.
Elucid Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 9, 2023 | ||||
| Series B | Jun 22, 2022 | ||||
| Series A | May 12, 2021 |
Key People
Founding team and executive leadership
Elucid Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioVerge Fund | Series B |
| Bold Brain | Series B |
| MedTex Ventures | Series B, Series C, Series A |
| BlueStone Venture Partners | Series B, Series C, Series A |
| Angel Physicians Fund | Series A |
| Biovision Ventures | Series B, Series C |
| Global Health Impact Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Commercial availability of the Lesion Inspection Tool for plaque analysis.
- Aug 5, 2025
Shamiram Feinglass, M.D. joins the board of directors.
Elucid Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elucid's valuation, stock price, and market status.
